Background of Study Sample Clauses

Background of Study. Today, in globalization era, there has been an increasing need, interest and demands for being able to master English, and able to communicate efficiently in English as our foreign language, it is important for us to know and understand what are the factors that can influence students learning process and understanding English language. Among these there are several factors that we have often known, the most prominent is the at students‟ attitudes. According to The Concise Oxford Dictionary, attitude is a “settled behavior, as indicating opinion”, or a “settled mode of thinking”. Allport (1935) defines, “attitude is a mental or neural state of readiness, organized through experience, exerting a directive or dynamic influence upon the individual‟s response to all objects and situations with which it is related” persistence of human behavior.” In the context English as a second language (SL), Student attitudes towards learning English have many things that we have discussed in everywhere. This thing will affect students‟learning process where this has received as special attention and various studies have been conducted to examine the role of learning attitudes towards students‟ achievement in understanding and learning English. In the article “Honey catches flies more than Ginger : Enhancing Arab students towards learning English” Xx Xxxxxx (2012) maintains that the type of students‟ attitude towards the target language and the teacher is a center criteria in determining students‟ success or failure in learning second language. In Indonesia, English is a categorized as a foreign language this language has been taught to students since elementary school. In this era many places of early childhood education programs have taught the basic foundation for understanding English until learning continues to the university level. But there an example lot of students consider, that English is a frightening xxxxxxx. When they hear an English word, the first thing that comes to their head is grammar and tenses which are full of formulas and sentences which hard to say. Basically students who give a good attitude will more easily to understand the lesson, than those who give a bad attitude. In fact, language is not just structure, lots of contented things in learning languages. Therefore, attitudes toward English languages are also the reason students have good English. According Xxxxxxxx (2015, p.241) high motivation and a positive attitude towards a second language an...
AutoNDA by SimpleDocs
Background of Study. People who live in society engage with one another and get along well. Interaction is a process in which one or more people influence one another. One part of the society who are vulnerable in facing temptations and pressures from their social environment are adolescents (Xxxxxxxxxx et al., 2019). They are trying to find the lifestyle that suits them best, and they frequently do this by making a lot of mistakes along the way (Xxxxxx et al., 2017). They undergo psychological changes that frequently result in excessive emotion, either for no reason or for a specific reason, and have physical changes to those that happen to the body's organs and other parts of the human body. While psychological changes happen due to adolescent emotional development patterns and changes in the social environment that influence adolescent interaction, these changes also occur because of the habit of emotional maturity in adolescence (Remschmidt, 2013). It can be concluced that when a person's behavior changes from childhood to adulthood, it is certain that they entering a transition period of adolescents. At this time, adolescents whose experiencing a transition were looking for a lifestyle that must follow what they want (Xxxxxxx: helping pre-teens and teenagers handle the changes, 2021). It is clear that adolescents adapt to their environment in different ways as they search for their sense of self, leading to conflict within the teenagers themselves. As a result, some risks are made as part of the maturation process along with changes that adolescents affect. Adolescents and teenagers may struggle to grasp their place in society because they are still in a labile developmental stage. Teenagers who struggle to fit in will develop sadness and sentiments of “not good enough” which will make them feel hopeless, resent society, and commit juvenile delinquency. Juvenile delinquency is defined as delinquency perpetrated by a person between the ages of 16 and 18 who engages in punishable conduct (Xxxx, N. 2022). Xxxxxxxxx (2003) stated that delinquency is commonly defined as an act performed by a minor that is against the government's law that has jurisdiction over the area. The lack of a definite definition for the term “delinquency” which designates its universally acceptable connotation, is now abundantly obvious. Nevertheless, delinquency in its broadest meaning is understood to refer to behaviors that fall under the scope of typical child misbehavior (Xxxxxxxx, 2021). Children...

Related to Background of Study

  • Background Screening VENDOR shall comply with all requirements of Sections 1012.32 and 1012.465, Florida Statutes, and all of its personnel who (1) are to be permitted access to school grounds when students are present, (2) will have direct contact with students, or (3) have access or control of school funds, will successfully complete the background screening required by the referenced statutes and meet the standards established by the statutes. This background screening will be conducted by SBBC in advance of VENDOR or its personnel providing any services under the conditions described in the previous sentence. VENDOR shall bear the cost of acquiring the background screening required by Section 1012.32, Florida Statutes, and any fee imposed by the Florida Department of Law Enforcement to maintain the fingerprints provided with respect to VENDOR and its personnel. The parties agree that the failure of VENDOR to perform any of the duties described in this section shall constitute a material breach of this Agreement entitling SBBC to terminate immediately with no further responsibilities or duties to perform under this Agreement. VENDOR agrees to indemnify and hold harmless SBBC, its officers and employees from any liability in the form of physical or mental injury, death or property damage resulting from VENDOR’s failure to comply with the requirements of this section or with Sections 1012.32 and 1012.465, Florida Statutes.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Tests and Preclinical and Clinical Trials The preclinical studies and clinical trials conducted by or, to the Company’s knowledge, on behalf of the Company, that are described in the Registration Statement, the Pricing Disclosure Package and the Prospectus, as applicable, and are intended to be submitted to the U.S. Food and Drug Administration (the “FDA”) or other comparable government entities, were and, if still ongoing, are being conducted in all material respects in accordance with experimental protocols, procedures and controls pursuant to accepted professional scientific standards and all Authorizations and Applicable Laws, including, without limitation, current Good Clinical Practices and Good Laboratory Practices and any applicable rules and regulations of the jurisdiction in which such trials and studies are being conducted; the descriptions of the results of such studies and trials contained in the Registration Statement, the Pricing Disclosure Package and the Prospectus are, to the Company’s knowledge, accurate and complete in all material respects and fairly present the data derived from such studies and trials; except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package and the Prospectus, the Company is not aware of any studies or trials, the results of which the Company believes reasonably call into question the study or trial results described or referred to in the Registration Statement, the Pricing Disclosure Package and the Prospectus when viewed in the context in which such results are described and the clinical stage of development; and, except to the extent disclosed in the Registration Statement, the Pricing Disclosure Package or the Prospectus, the Company has not received any written notices or written correspondence from the FDA or any governmental entity requiring the termination or suspension of any preclinical studies or clinical trials conducted by or on behalf of the Company, other than ordinary course communications with respect to modifications in connection with the design and implementation of such trials, copies of which communications have been made available to you.

  • DEVELOPMENT OR ASSISTANCE IN DEVELOPMENT OF SPECIFICATIONS REQUIREMENTS/ STATEMENTS OF WORK

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Feasibility Study A feasibility study will identify the potential costs, service quality and other benefits which would result from contracting out the work in question. The cost analysis for the feasibility study shall not include the Employer’s indirect overhead costs for existing salaries or wages and benefits for administrative staff or for rent, equipment, utilities, and materials, except to the extent that such costs are attributable solely to performing the services to be contracted out. Upon completion of the feasibility study, the Employer agrees to furnish the Union with a copy if the feasibility study, the bid from the Apparent Successful Bidder and all pertinent information upon which the Employer based its decision to contract out the work including, but not limited to, the total cost savings the Employer anticipates. The Employer shall not go forward with contracting out the work in question if more than sixty percent (60%) of any projected savings resulting from the contracting out are attributable to lower employee wage and benefit costs.

  • Technical Feasibility of String While ICANN has encouraged and will continue to encourage universal acceptance of all top-­‐level domain strings across the Internet, certain top-­‐level domain strings may encounter difficulty in acceptance by ISPs and webhosters and/or validation by web applications. Registry Operator shall be responsible for ensuring to its satisfaction the technical feasibility of the TLD string prior to entering into this Agreement.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Concession Area, including its abandonment.

  • Background Investigation The BOARD is prohibited from knowingly employing a person who has been convicted of committing or attempting to commit certain criminal offenses. If the required criminal background investigation is not completed at the time this Contract is signed, and the subsequent investigation report reveals that there has been a prohibited conviction, this Contract shall immediately become null and void.

  • Project Background 6.1.1. Brief description of Contracting Agency’s project background and/or situation leading to this Project

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!